6506 Predictive markers in patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab in a multicenter phase II trial

2009 ◽  
Vol 7 (2) ◽  
pp. 363
Author(s):  
K. Rohrberg ◽  
H. Pappot ◽  
B.G. Skov ◽  
G. Høyer-Hansen ◽  
I.J. Christensen ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Predictive Markers ◽  
Gastrointestinal Cancers ◽  
Multicenter Phase ◽  
Upper Gastrointestinal

scholarly journals Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers

2011 ◽  
Vol 51 (2) ◽  
pp. 234-242 ◽  
Author(s):  
Kristoffer S. Rohrberg ◽  
René K. Olesen ◽  
Per Pfeiffer ◽  
Morten Ladekarl ◽  
Helle Pappot ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Gastrointestinal Cancers ◽  
Upper Gastrointestinal

scholarly journals A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

Cancer ◽  
1999 ◽  
Vol 85 (4) ◽  
pp. 786-795 ◽  
Author(s):  
Mace L. Rothenberg ◽  
John V. Cox ◽  
Russell F. DeVore ◽  
John D. Hainsworth ◽  
Richard Pazdur ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Multicenter Phase ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document